EP 1056774 A1 20001206 - N-TERMINALLY TRUNCATED GLP-1 DERIVATIVES
Title (en)
N-TERMINALLY TRUNCATED GLP-1 DERIVATIVES
Title (de)
N-TERMINAL VERKÜRZTE GLP-1 DERIVATE
Title (fr)
DERIVES DE GLP-1 TRONQUES A L'EXTREMITE N-TERMINALE
Publication
Application
Priority
- DK 9900081 W 19990225
- DK 26498 A 19980227
- DK 50998 A 19980408
Abstract (en)
[origin: WO9943705A1] The present invention relates to N-terminally truncated derivatives of human glucagon-like peptide-1 (GLP-1) and analogues thereof having a protracted profile of action, as well as the use of such derivatives in pharmaceutical compositions for the treatment of obesity, insulin dependent or non-insulin dependent diabetes mellitus. The GLP-1 derivatives have a lipophilic substituent attached to at least one amino acid residue.
IPC 1-7
IPC 8 full level
A61K 38/22 (2006.01); A61K 38/26 (2006.01); A61K 38/28 (2006.01); A61P 3/04 (2006.01); A61P 3/10 (2006.01); A61P 5/50 (2006.01); C07K 14/605 (2006.01); C12N 15/09 (2006.01); A61K 38/00 (2006.01)
CPC (source: EP)
A61K 38/2264 (2013.01); A61K 38/26 (2013.01); A61K 38/28 (2013.01); A61P 3/04 (2017.12); A61P 3/10 (2017.12); A61P 5/50 (2017.12); C07K 14/605 (2013.01)
Citation (search report)
See references of WO 9943705A1
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU NL PT SE
DOCDB simple family (publication)
WO 9943705 A1 19990902; WO 9943705 A8 19991014; AU 2610599 A 19990915; EP 1056774 A1 20001206; JP 2002508162 A 20020319
DOCDB simple family (application)
DK 9900081 W 19990225; AU 2610599 A 19990225; EP 99906075 A 19990225; JP 2000533455 A 19990225